Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Division of Experimental Therapeutics, Collage of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
The therapeutic potential for human embryonic stem cells (hESC) drives intense public and scientific interest. However, the classical approach for derivation of hESC entails the destruction of human embryos. Controversial ethical issues and correspondingly restrictive federal policies in many countries have prompted the development of alternative approaches for the isolation of hESC. Here, several different strategies are discussed with a focus on the harvesting of live hESC from dead embryos.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on